Viewing Study NCT06826768


Ignite Creation Date: 2025-12-24 @ 5:41 PM
Ignite Modification Date: 2025-12-25 @ 3:10 PM
Study NCT ID: NCT06826768
Status: RECRUITING
Last Update Posted: 2025-12-18
First Post: 2025-02-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module